Neuropeptides Involved in the Pathophysiology of Schizophrenia and Major Depression

References

• Agren , H. and Lundqvist , G. 1984 . "Low levels of somatostatin in human CSF mark depressive episodes" . Psychoneuroendocrinology , 9 : 233 – 248 .
   PubMedGoogle Scholar
• Albus , M. , von Gellhorn , K. , Munch , U. , Naber , D. and Ackenheil , M. 1986 . "A double-blind study with ceruletide in chronic schizophrenic patients: biochemical and clinical results" . Psychiatry Res. , 19 : 1 – 7 .
   PubMedGoogle Scholar
• Arato , M. , Banki , C.M. , Nemeroff , C.B. and Bissette , G. 1986 . "Hypothalamic-pituitary-adrenal axis and suicide" . Ann. NY Acad. Sci. , 487 : 263 – 270 .
   PubMedGoogle Scholar
• Arato , M. , Banki , C.M. , Bissette , G. and Nemeroff , C.B. 1989 . "Elevated CSF CRF in suicide victims" . Biol. Psychiatry , 25 : 355 – 359 .
   PubMed Web of Science ®Google Scholar
• Arborelius , L. , Owens , M.J. , Plotsky , P.M. and Nemeroff , C.B. 1999 . "The role of corticotropin-releasing factor in depression and anxiety disorders" . J. Endocrinol. , 160 : 1 – 12 .
   PubMed Web of Science ®Google Scholar
• Asher , R. 1949 . "Myxoedematous madness" . Br. Med. J. , 22 : 555 – 562 .
   Google Scholar
• Austin , J. , Hoogendoorn , B. , Buckland , P. , Speight , G. , Cardno , A. , Bowen , T. , Williams , N. , Spurlock , G. , Sanders , R. , Jones , L. , Murphy , K. , McCarthy , G. , McGuffin , P. , Owen , M.J. and O'Donovan , M.C. 2000a . "Comparative sequencing of the proneurotensin gene and association studies in schizophrenia" . Mol. Psychiatry , 5 (2) : 208 – 212 .
   PubMedGoogle Scholar
• Austin , J. , Buckland , P. , Cardno , A.G. , Williams , N. , Spurlock , G. , Hoogendoorn , B. , Zammit , S. , Jones , G. , Sanders , R. , Jones , L. , McCarthy , G. , Jones , S. , Bray , N.J. , McGuffin , P. , Owen , M.J. and O'Donovan , M.C. 2000b . "The high affinity neurotensin receptor gene (NTSR1): comparative sequencing and association studies in schizophrenia" . Mol. Psychiatry , 5 (5) : 552 – 557 .
   PubMedGoogle Scholar
• Azorin , J.M. , Blum , A. , Charbaut , J. , Escande , M. , Granier , F. , Huber , J.P. , Metzger , J.Y. , Richou , H. , Sitsen , A. Van Amerongen , P. 1990 . "Des-enkephalin-gamma-endorphin in the treatment of schizophrenia" . Int. Clin. Psychopharmacol. , 5 : 205 – 215 .
   PubMedGoogle Scholar
• Bachus , S.E. , Hyde , T.M. , Herman , M.M. , Egan , M.F. and Kleinman , J.E. 1997 . "Abnormal cholecystokinin mRNA levels in entorhinal cortex of schizophrenics" . J. Psychiatr. Res. , 31 : 233 – 256 .
   PubMed Web of Science ®Google Scholar
• Banki , C.M. , Bissette , G. , Arato , M. , O'Connor , L. and Nemeroff , C.B. 1987 . "CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia" . Am. J. Psychiatry , 144 : 873 – 877 .
   PubMed Web of Science ®Google Scholar
• Banki , C.M. , Bissette , G. , Arato , M. and Nemeroff , C.B. 1988 . "Elevation of immunoreactive CSF TRH in depressed patients" . Am. J. Psychiatry , 145 : 1526 – 1531 .
   PubMed Web of Science ®Google Scholar
• Banki , C.M. , Karmacsi , L. , Bissette , G. and Nemeroff , C.B. 1992a . "CSF corticotropin releasing hormone, somatostatin, and thyrotropin releasing hormone in schizophrenia" . Psychiatry Res. , 43 (1) : 13 – 21 .
   PubMedGoogle Scholar
• Banki , C.M. , Karmacsi , L. , Bissette , G. and Nemeroff , C.B. 1992b . "Cerebrospinal fluid neuropeptides in mood disorder and dementia" . J. Affect. Disord. , 25 : 39 – 45 .
   PubMed Web of Science ®Google Scholar
• Barberis , C. and Tribollet , E. 1996 . "Vasopressin and oxytocin receptors in the central nervous system" . Crit. Rev. Neurobiol. , 10 : 119 – 154 .
   PubMed Web of Science ®Google Scholar
• Beal , M.F. , Svendsen , C.N. , Bird , E.D. and Martin , J.B. 1987 . "Somatostatin and neuropeptide Y are unaltered in the amygdala in schizophrenia" . Neurochem. Pathol. , 6 (3) : 169 – 176 .
   PubMedGoogle Scholar
• Bean , A.J. , Dagerlind , A. , Hokfelt , T. and Dobner , P.R. 1992 . "Cloning of human neurotensin/neuromedin N genomic sequences and expression in the ventral mesencephalon of schizophrenics and age/sex matched controls" . Neuroscience , 50 (2) : 259 – 268 .
   PubMedGoogle Scholar
• Beckmann , H. , Lang , R.E. and Gattaz , W.F. 1985 . "Vasopressin--oxytocin in cerebrospinal fluid of schizophrenic patients and normal controls" . Psychoneuroendocrinology , 10 : 187 – 191 .
   PubMed Web of Science ®Google Scholar
• Beinfeld , M.C. and Garver , D.L. 1991 . "Concentration of cholecystokinin in cerebrospinal fluid is decreased in psychosis: relationship to symptoms and drug response" . Prog. Neuropsychopharmacol. Biol. Psychiatry , 15 : 601 – 609 .
   PubMedGoogle Scholar
• Berrettini , W.H. , Rubinow , D.R. , Nurnberger , J.I. Jr , Simmons-Alling , S. , Post , R.M. and Gershon , E.S. 1985 . "CSF substance P immunoreactivity in affective disorders" . Biol. Psychiatry , 20 : 965 – 970 .
   PubMed Web of Science ®Google Scholar
• Berrettini , W.H. , Doran , A.R. , Kelsoe , J. , Roy , A. and Pickar , D. 1987 . "Cerebrospinal fluid neuropeptide Y in depression and schizophrenia" . Neuropsychopharmacology , 1 (1) : 81 – 83 .
   PubMedGoogle Scholar
• Biggins , J.A. , Perry , E.K. , McDermott , J.R. , Smith , A.I. , Perry , R.H. and Edwardson , J.A. 1983 . "Post mortem levels of thyrotropin-releasing hormone and neurotensin in the amygdala in Alzheimer's disease, schizophrenia and depression" . J. Neurol. Sci. , 58 (1) : 117 – 122 .
   PubMedGoogle Scholar
• Bissette , G. , Widerlov , E. , Walleus , H. , Karlsson , I. , Eklund , K. , Forsman , A. and Nemeroff , C.B. 1986 . "Alterations in cerebrospinal fluid concentrations of somatostatinlike immunoreactivity in neuropsychiatric disorders" . Arch. Gen. Psychiatry , 43 : 1148 – 1151 .
   PubMedGoogle Scholar
• Bloom , F. , Segal , D. , Ling , N. and Guillemin , R. 1976 . "Endorphins: profound behavioral effects in rats suggest new etiological factors in mental illness" . Science , 194 : 630 – 632 .
   PubMed Web of Science ®Google Scholar
• Bourgeois , M. , Laforge , E. , Muyard , J. , Blayac , J. and Lemoine , J. 1980 . "Endorphins and schizophrenias. II. Trial treatment of schizophrenia with des-Tyr-gamma-endorphin (DT gamma E) (including a personal trial)" . Ann. Med. Psychol. (Paris) , 138 : 1112 – 1119 .
   PubMedGoogle Scholar
• Brambilla , F. , Aguglia , E. , Massironi , R. , Maggioni , M. , Grillo , W. , Castiglioni , R. , Catalano , M. and Drago , F. 1986 . "Neuropeptide therapies in chronic schizophrenia: TRH and vasopressin administration" . Neuropsychobiology , 15 : 114 – 121 .
   PubMedGoogle Scholar
• Brambilla , F. , Bondiolotti , G.P. , Maggioni , M. , Sciascia , A. , Grillo , W. , Sanna , F. , Latina , A. and Picotti , G.B. 1989 . "Vasopressin (DDAVP) therapy in chronic schizophrenia: effects on negative symptoms and memory" . Neuropsychobiology , 20 : 113 – 119 .
   PubMedGoogle Scholar
• Breslin , N.A. , Suddath , R.L. , Bissette , G. , Nemeroff , C.B. , Lowrimore , P. and Weinberger , D.R. 1994 . "CSF concentrations of neurotensin in schizophrenia: an investigation of clinical and biochemical correlates" . Schizophr. Res. , 12 (1) : 35 – 41 .
   PubMedGoogle Scholar
• Burnet , P.W. and Harrison , P.J. 2000 . "Substance P (NK1) receptors in the cingulate cortex in unipolar and bipolar mood disorder and schizophrenia" . Biol. Psychiatry , 47 : 80 – 83 .
   PubMed Web of Science ®Google Scholar
• Caberlotto , L. and Hurd , Y.L. 1999 . "Reduced neuropeptide Y mRNA expression in the prefrontal cortex of subjects with bipolar disorder" . Neuroreport , 10 (8) : 1747 – 1750 .
   PubMedGoogle Scholar
• Caberlotto , L. and Hurd , Y.L. 2001 . "Neuropeptide Y Y(1)and Y(2) receptor mRNA expression in the prefrontal cortex of psychiatric subjects. Relationship of Y(2) subtype to suicidal behavior" . Neuropsychopharmacology , 25 (1) : 91 – 97 .
   PubMedGoogle Scholar
• Carraway , R.E. and Leeman , S.E. 1973 . "The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami" . J. Biol. Chem. , 248 : 6854
   PubMed Web of Science ®Google Scholar
• Carraway , R.E. and Leeman , S.E. 1976 . "Characterization of radioimmunoassayable neurotensin in the rat: its differential distribution in the central nervous system, small intestine and stomach" . J. Biol. Chem. , 254 : 7045
   Google Scholar
• Carroll , B.J. 1982 . "Use of the dexamethasone suppression test in depression" . J. Clin. Psychiatry , 43 : 44 – 50 .
   PubMedGoogle Scholar
• Casey , D.E. , Korsgaard , S. , Gerlach , J. , Jorgensen , A. and Simmelsgaard , H. 1981 . "Effect of des-tyrosine-gamma-endorphin in tardive dyskinesia" . Arch. Gen. Psychiatry , 38 : 158 – 160 .
   PubMedGoogle Scholar
• Charlton , B.G. , Wright , C. , Leake , A. , Ferrier , I.N. , Cheetham , S.C. , Horton , R.W. , Crompton , M.R. and Katona , C.L. 1988 . "Somatostatin immunoreactivity in postmortem brain from depressed suicides" . Arch. Gen. Psychiatry , 45 : 597 – 598 .
   PubMedGoogle Scholar
• Coppen , A. 1967 . "The biochemistry of affective disorders" . Br. J. Psychiatry , 113 : 1237 – 1264 .
   PubMed Web of Science ®Google Scholar
• Crawley , J.N. 1991 . "Cholecystokinin-dopamine interactions" . Trends Pharmacol. Sci. , 12 : 232 – 236 .
   PubMed Web of Science ®Google Scholar
• Croiset , G. , Nijsen , M.J. and Kamphuis , P.J. 2000 . "Role of corticotropin-releasing factor, vasopressin and the autonomic nervous system in learning and memory" . Eur. J. Pharmacol. , 405 : 225 – 234 .
   PubMed Web of Science ®Google Scholar
• DeBattista , C. , Posener , J.A. , Kalehzan , B.M. and Schatzberg , A.F. 2000 . "Acute antidepressant effects of intravenous hydrocortisone and CRH in depressed patients: a double-blind, placebo-controlled study" . Am. J. Psychiatry , 157 : 1334 – 1337 .
   PubMed Web of Science ®Google Scholar
• De Bellis , M.D. , Gold , P.W. , Geracioti , T.D. Jr. , Listwak , S.J. and Kling , M.A. 1993 . "Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression" . Am. J. Psychiatry , 150 : 656 – 657 .
   PubMed Web of Science ®Google Scholar
• De Souza , E.B. 1995 . "Corticotropin-releasing factor receptors: physiology, pharmacology, biochemistry and role in central nervous system and immune disorders" . Psychoneuroendocrinology , 20 : 789 – 819 .
   PubMed Web of Science ®Google Scholar
• Detera-Wadleigh , S.D. , De Miguel , C. , Berrettini , W.H. , DeLisi , L.E. , Goldin , L.R. and Gershon , E.S. 1987 . "Neuropeptide gene polymorphisms in affective disorder and schizophrenia" . J. Psychiatr. Res. , 21 : 581 – 587 .
   PubMedGoogle Scholar
• De Wied , D. , Kovacs , G.L. , Bohus , B. , Van Ree , J.M. and Greven , H.M. 1978 . "Neuroleptic activity of the neuropeptide beta-LPH62-77 ([Des-Tyr1]gamma-endorphin; DT gamma E)" . Eur. J. Pharmacol. , 49 : 427 – 436 .
   PubMed Web of Science ®Google Scholar
• De Wied , D. and Burbach , J.P.H. 1999 . "Neuropeptides and behavior" ” . In Encyclopedia of Neuroscience , Edited by: Adelman , G. and Smith , B.H. 1431 – 1436 . Boston : Birkhäuser .
   Google Scholar
• Dinan , T.G. 1994 . "Glucocorticoids and the genesis of depressive illness. A psychobiological model" . Br. J. Psychiatry , 164 : 365 – 371 .
   PubMed Web of Science ®Google Scholar
• Dinan , T.G. , Lavelle , E. , Scott , L.V. , Newell-Price , J. , Medbak , S. and Grossman , A.B. 1999 . "Desmopressin normalizes the blunted adrenocorticotropin response to corticotropin-releasing hormone in melancholic depression: evidence of enhanced vasopressinergic responsivity" . J. Clin. Endocrinol. Metab. , 84 : 2238 – 2240 .
   PubMedGoogle Scholar
• Doran , A.R. , Rubinow , D.R. , Roy , A. and Pickar , D. 1986 . "CSF somatostatin and abnormal response to dexamethasone administration in schizophrenic and depressed patients" . Arch. Gen. Psychiatry , 43 : 365 – 369 .
   PubMedGoogle Scholar
• Duval , F. , Macher , J.P. and Mokrani , M.C. 1990 . "Difference between evening and morning thyrotropin responses to protirelin in major depressive episode" . Arch. Gen. Psychiatry , 47 : 443 – 448 .
   PubMed Web of Science ®Google Scholar
• Duval , F. , Mokrani , M.C. , Bailey , P. , Correa , H. , Diep , T.S. , Crocq , M.A. and Macher , J.P. 1999 . "Thyroid axis activity and serotonin function in major depressive episode" . Psychoneuroendocrinology , 24 : 695 – 712 .
   PubMed Web of Science ®Google Scholar
• Emrich , H.M. , Zaudig , M. , Kissling , W. , Dirlich , G. , von Zerssen , D. and Herz , A. 1980 . "Des-tyrosyl-gamma-endorphin in schizophrenia: a double-blind trial in 13 patients" . Pharmakopsychiatr. Neuro-Psychopharmakol. , 13 : 290 – 298 .
   PubMedGoogle Scholar
• Farmery , S.M. , Owen , F. , Poulter , M. and Crow , T.J. 1985 . "Reduced high affinity cholecystokinin binding in hippocampus and frontal cortex of schizophrenic patients" . Life Sci. , 36 : 473 – 477 .
   PubMedGoogle Scholar
• Ferrier , I.N. , Roberts , G.W. , Crow , T.J. , Johnstone , E.C. , Owens , D.G. , Lee , Y.C. , O'Shaughnessy , D. , Adrian , T.E. , Polak , J.M. and Bloom , S.R. 1983 . "Reduced cholecystokinin-like and somatostatin-like immunoreactivity in limbic lobe is associated with negative symptoms in schizophrenia" . Life Sci. , 33 : 475 – 482 .
   PubMed Web of Science ®Google Scholar
• Fink , M. , Papakostas , Y. and Lee , J. 1981 . "Clinical trials with des-tyr-gamma-endorphin (GK-78)" ” . In Biological Psychiatry , Edited by: Perris , C. , Struwe , G. and Jansson , B. Amsterdam : Elsevier/North-Holland Biomedical Press .
   Google Scholar
• France , R.D. , Urban , B. , Krishnan , K.R. , Bissett , G. , Banki , C.M. , Nemeroff , C. and Speilman , F.J. 1988 . "CSF corticotropin-releasing factor-like immunoactivity in chronic pain patients with and without major depression" . Biol. Psychiatry , 23 : 86 – 88 .
   PubMedGoogle Scholar
• Frasch , A. , Zetzsche , T. , Steiger , A. and Jirikowski , G.F. 1995 . "Reduction of plasma oxytocin levels in patients suffering from major depression" . Adv. Exp. Med. Biol. , 395 : 257 – 258 .
   PubMedGoogle Scholar
• Frederiksen , S.O. , Ekman , R. , Gottfries , C.G. , Widerlov , E. and Jonsson , S. 1991 . "Reduced concentrations of galanin, arginine vasopressin, neuropeptide Y and peptide YY in the temporal cortex but not in the hypothalamus of brains from schizophrenics" . Acta Psychiatr. Scand. , 83 : 273 – 277 .
   PubMed Web of Science ®Google Scholar
• Frye , M.A. , Dunn , R.T. , Gary , K.A. , Kimbrell , T.A. , Callahan , A.M. , Luckenbaugh , D.A. , Cora-Locatelli , G. , Vanderham , E. , Winokur , A. and Post , R.M. 1999 . "Lack of correlation between cerebrospinal fluid thyrotropin-releasing hormone (TRH) and TRH-stimulated thyroid-stimulating hormone in patients with depression" . Biol. Psychiatry , 45 : 1049 – 1052 .
   PubMedGoogle Scholar
• Gabriel , S.M. , Davidson , M. , Haroutunian , V. , Powchik , P. , Bierer , L.M. , Purohit , D.P. , Perl , D.P. and Davis , K.L. 1996 . "Neuropeptide deficits in schizophrenia vs. Alzheimer's disease cerebral cortex" . Biol. Psychiatry , 39 : 82 – 91 .
   PubMed Web of Science ®Google Scholar
• Gaffori , O. , Stewart , J.M. and De Wied , D. 1984 . "Influence of substance P and fragments on passive avoidance behavior" . Experientia , 40 : 89 – 91 .
   PubMedGoogle Scholar
• Garver , D.L. , Beinfeld , M.C. and Yao , J.K. 1990 . "Cholecystokinin, dopamine and schizophrenia" . Psychopharmacol. Bull. , 26 : 377 – 380 .
   PubMedGoogle Scholar
• Garver , D.L. , Bissette , G. , Yao , J.K. and Nemeroff , C.B. 1991 . "Relation of CSF neurotensin concentrations to symptoms and drug response of psychotic patients" . Am. J. Psychiatry , 148 (4) : 484 – 488 .
   PubMedGoogle Scholar
• Geracioti , T.D. Jr , Orth , D.N. , Ekhator , N.N. , Blumenkopf , B. and Loosen , P.T. 1992 . "Serial cerebrospinal fluid corticotropin-releasing hormone concentrations in healthy and depressed humans" . J. Clin. Endocrinol. Metab. , 74 : 1325 – 1330 .
   PubMedGoogle Scholar
• Gerner , R.H. and Yamada , T. 1982 . "Altered neuropeptide concentrations in cerebrospinal fluid of psychiatric patients" . Brain Res. , 238 : 298 – 302 .
   PubMedGoogle Scholar
• Gerner , R.H. , Van Kammen , D.P. and Ninan , P.T. 1985 . "Cerebrospinal fluid cholecystokinin, bombesin and somatostatin in schizophrenia and normals" . Prog. Neuropsychopharmacol. Biol. Psychiatry , 9 : 73 – 82 .
   PubMedGoogle Scholar
• Gispen-de , Wied , C.C. , Kok , F.W. , Koppeschaar , H.P. , Wynne , H.J. , Westenberg , H.G. , Thijssen , J.H. and Van Ree , J.M. 1993 . "Stimulation of the pituitary-adrenal system with graded doses of CRH and low dose vasopressin infusion in depressed patients and healthy subjects: a pilot study" . Eur. Neuropsychopharmacol. , 3 : 533 – 541 .
   PubMedGoogle Scholar
• Gjerris , A. , Hammer , M. , Vendsborg , P. , Christensen , N.J. and Rafaelsen , O.J. 1985 . "Cerebrospinal fluid vasopressin--changes in depression" . Br. J. Psychiatry , 147 : 696 – 701 .
   PubMed Web of Science ®Google Scholar
• Gjerris , A. , Widerlov , E. , Werdelin , L. and Ekman , R. 1992 . "Cerebrospinal fluid concentrations of neuropeptide Y in depressed patients and in controls" . J. Psychiatry Neurosci. , 17 (1) : 23 – 27 .
   PubMedGoogle Scholar
• Glovinsky , D. , Kalogeras , K.T. , Kirch , D.G. , Suddath , R. and Wyatt , R.J. 1994 . "Cerebrospinal fluid oxytocin concentration in schizophrenic patients does not differ from control subjects and is not changed by neuroleptic medication" . Schizophr. Res. , 11 : 273 – 276 .
   PubMed Web of Science ®Google Scholar
• Gold , P.W. , Goodwin , F.K. , Post , R.M. and Robertson , G.L. 1981 . "Vasopressin function in depression and mania [proceedings]" . Psychopharmacol. Bull. , 17 : 7 – 9 .
   PubMedGoogle Scholar
• Goldstein , G. , Fava , M. , Culler , M. , Fisher , A. , Rickels , K. , Lydiard , R.B. and Rosenbaum , J. 2000 . "Elevated plasma thymopoietin associated with therapeutic nonresponsiveness in major depression" . Biol. Psychiatry , 48 : 65 – 69 .
   PubMedGoogle Scholar
• Harrison , S. and Geppetti , P. 2001 . "Substance P" . Int. J. Biochem. Cell Biol. , 33 : 555 – 576 .
   PubMed Web of Science ®Google Scholar
• Hashimoto , H. , Onishi , H. , Koide , S. , Kai , T. and Yamagami , S. 1996 . "Plasma neuropeptide Y in patients with major depressive disorder" . Neurosci. Lett. , 216 (1) : 57 – 60 .
   PubMedGoogle Scholar
• Heikkila , L. 1993 . "Somatostatin in the cerebrospinal fluid of schizophrenic patients before and after neuroleptic drug treatment" . Schizophr. Res. , 8 (3) : 273 – 277 .
   PubMedGoogle Scholar
• Heikkila , L. , Rimon , R. , Terenius , L. and Dynorphin , A. 1990 . "substance P in the cerebrospinal fluid of schizophrenic patients" . Psychiatry Res. , 34 : 229 – 236 .
   PubMedGoogle Scholar
• Hein , M.D. and Jackson , I.M. 1990 . "Review: thyroid function in psychiatric illness" . Gen. Hosp. Psychiatry , 12 : 232 – 244 .
   PubMedGoogle Scholar
• Hermes , M.L. and Renaud , L.P. 1993 . "Differential responses of identified rat hypothalamic paraventricular neurons to suprachiasmatic nucleus stimulation" . Neuroscience , 56 : 823 – 832 .
   PubMedGoogle Scholar
• Heuser , I. , Bissette , G. , Dettling , M. , Schweiger , U. , Gotthardt , U. , Schmider , J. , Lammers , C.H. , Nemeroff , C.B. and Holsboer , F. 1998 . "Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin and somatostatin in depressed patients and healthy controls: response to amitriptyline treatment" . Depress. Anxiety , 8 : 71 – 79 .
   PubMedGoogle Scholar
• Holsboer , F. 2000 . "The corticosteroid receptor hypothesis of depression" . Neuropsychopharmacology , 23 : 477 – 501 .
   PubMed Web of Science ®Google Scholar
• Holsboer , F. and Barden , N. 1996 . "Antidepressants and hypothalamic-pituitary-adrenocortical regulation" . Endocr. Rev. , 17 : 187 – 205 .
   PubMed Web of Science ®Google Scholar
• Holsboer , F. , Lauer , C.J. , Schreiber , W. and Krieg , J.C. 1995 . "Altered hypothalamic-pituitary-adrenocortical regulation in healthy subjects at high familial risk for affective disorders" . Neuroendocrinology , 62 : 340 – 347 .
   PubMed Web of Science ®Google Scholar
• Hommer , D.W. , Pickar , D. , Roy , A. , Ninan , P. , Boronow , J. and Paul , S.M. 1984 . "The effects of ceruletide in schizophrenia" . Arch. Gen. Psychiatry , 41 : 617 – 619 .
   PubMedGoogle Scholar
• Hoogendijk , W.J. , Purba , J.S. , Hofman , M.A. , De Vos , R.A. , Jansen , E.N. and Swaab , D.F. 1998 . "Depression in Parkinson's disease is not accompanied by more corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus" . Biol. Psychiatry , 43 : 913 – 917 .
   PubMedGoogle Scholar
• Hucks , D. , Lowther , S. , Crompton , M.R. , Katona , C.L. and Horton , R.W. 1997 . "Corticotropin-releasing factor binding sites in cortex of depressed suicides" . Psychopharmacology (Berl) , 134 : 174 – 178 .
   PubMed Web of Science ®Google Scholar
• Iadarola , M.J. , Ofri , D. and Kleinman , J.E. 1991 . "Enkephalin, dynorphin and substance P in postmortem substantia nigra from normals and schizophrenic patients" . Life Sci. , 48 : 1919 – 1930 .
   PubMedGoogle Scholar
• Iager , A.C. , Kirch , D.G. , Bigelow , L.B. and Karson , C.N. 1986 . "Treatment of schizophrenia with a vasopressin analogue" . Am. J. Psychiatry , 143 : 375 – 377 .
   PubMedGoogle Scholar
• Inder , W.J. , Donald , R.A. , Prickett , T.C. , Frampton , C.M. , Sullivan , P.F. , Mulder , R.T. and Joyce , P.R. 1997 . "Arginine vasopressin is associated with hypercortisolemia and suicide attempts in depression" . Biol. Psychiatry , 42 : 744 – 747 .
   PubMed Web of Science ®Google Scholar
• Iritani , S. , Kuroki , N. , Niizato , K. and Ikeda , K. 2000 . "Morphological changes in neuropeptide Y-positive fiber in the hippocampal formation of schizophrenics" . Prog. Neuropsychopharmacol. Biol. Psychiatry , 24 (2) : 241 – 249 .
   PubMedGoogle Scholar
• Irwin , M. , Brown , M. , Patterson , T. , Hauger , R. , Mascovich , A. and Grant , I. 1991 . "Neuropeptide Y and natural killer cell activity: findings in depression and Alzheimer caregiver stress" . FASEB. J. , 5 (15) : 3100 – 3107 .
   PubMedGoogle Scholar
• Ishunina , T.A. and Swaab , D.F. 1999 . "Vasopressin and oxytocin neurons of the human supraoptic and paraventricular nucleus: size changes in relation to age and sex" . J. Clin. Endocrinol. Metab , 84 : 4637 – 4644 .
   PubMed Web of Science ®Google Scholar
• Jackson , I.M. 1998 . "The thyroid axis and depression" . Thyroid , 8 : 951 – 956 .
   PubMed Web of Science ®Google Scholar
• Jacquet , Y.F. and Marks , N. 1976 . "The C-fragment of beta-lipotropin: an endogenous neuroleptic or antipsychotogen?" . Science , 194 : 632 – 635 .
   PubMed Web of Science ®Google Scholar
• Joja , O. , Goldstein , R. and Popa , M. 1993 . "Vasotocin effects in depressive patients with eating disorders" . Rom. J. Endocrinol. , 31 : 171 – 177 .
   PubMedGoogle Scholar
• Kaiya , H. , Tamura , Y. , Adachi , S. , Moriuchi , I. , Namba , M. , Tanaka , M. , Yoshida , H. , Yanaihara , N. and Yanaihara , C. 1981 . "Substance P-like immunoreactivity in plasma of psychotic patients and effects of neuroleptics and electroconvulsive therapy" . Psychiatry Res. , 5 : 11 – 21 .
   PubMedGoogle Scholar
• Kasckow , J.W. , Baker , D. and Geracioti , T.D. Jr. 2001 . "Corticotropin-releasing hormone in depression and post-traumatic stress disorder" . Peptides , 22 : 845 – 851 .
   PubMed Web of Science ®Google Scholar
• Kathol , R.G. , Jaeckle , R.S. , Lopez , J.F. and Meller , W.H. 1989 . "Consistent reduction of ACTH responses to stimulation with CRH, vasopressin and hypoglycaemia in patients with major depression" . Br. J. Psychiatry , 155 : 468 – 478 .
   PubMedGoogle Scholar
• Keck , M.E. and Holsboer , F. 2001 . "Hyperactivity of CRH neuronal circuits as a target for therapeutic interventions in affective disorders" . Peptides , 22 : 835 – 844 .
   PubMed Web of Science ®Google Scholar
• Kerwin , R. , Robinson , P. and Stewart , J.M. 1992 . "Distribution of CCK binding sites in the human hippocampal formation and their alteration in schizophrenia: a post-mortem autoradiographic study" . Psychol. Med. , 22 : 37 – 43 .
   PubMedGoogle Scholar
• Kirkegaard , C. , Faber , J. , Hummer , L. and Rogowski , P. 1979 . "Increased levels of TRH in cerebrospinal fluid from patients with endogenous depression" . Psychoneuroendocrinology , 4 : 227 – 235 .
   PubMedGoogle Scholar
• Kinkead , B. and Nemeroff , C.B. 2002 . "Neurotensin: an endogenous antipsychotic?" . Curr. Opin. Pharmacol. , 2 (1) : 99 – 103 .
   PubMedGoogle Scholar
• Kissling , W. , Moller , J.H. , Cootjans , J , Roy , D. , Husebö , B. , Christiansen , P. and Godt , H.H. "Multicenter double-blind comparison between des-enkephalin-γ-endorphin (DEγE, Org 5878) and haloperidol concerning the efficacy and safety in the treatment of schizophrenia" . Psychiatry, Its Related Disciplines, the Next 25 Years: World Psychiatric Association, Regional Symposium . pp. 178
   Google Scholar
• Kleinman , J.E. , Hong , J. , Iadarola , M. , Govoni , S. and Gillin , C.J. 1985 . "Neuropeptides in human brain-postmortem studies" . Prog. Neuropsychopharmacol. Biol. Psychiatry , 9 : 91 – 95 .
   PubMedGoogle Scholar
• Kling , M.A. , Roy , A. , Doran , A.R. , Calabrese , J.R. , Rubinow , D.R. , Whitfield , H.J. Jr , May , C. , Post , R.M. , Chrousos , G.P. and Gold , P.W. 1991 . "Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: potential clinical implications" . J. Clin. Endocrinol. Metab. , 72 : 260 – 271 .
   PubMed Web of Science ®Google Scholar
• Kling , M.A. , Rubinow , D.R. , Doran , A.R. , Roy , A. , Davis , C.L. , Calabrese , J.R. , Nieman , L.K. , Post , R.M. , Chrousos , G.P. and Gold , P.W. 1993 . "Cerebrospinal fluid immunoreactive somatostatin concentrations in patients with Cushing's disease and major depression: relationship to indices of corticotropin-releasing hormone and cortisol secretion" . Neuroendocrinology , 57 : 79 – 88 .
   PubMedGoogle Scholar
• Korsgaard , S. , Casey , D.E. , Damgaard Pedersen , N.E. , Jorgensen , A. and Gerlach , J. 1981 . "Vasopressin in anergic schizophrenia. A cross-over study with lysine-8-vasopressin and placebo" . Psychopharmacology (Berl) , 74 : 379 – 382 .
   PubMedGoogle Scholar
• Korsgaard , S. , Casey , D.E. and Gerlach , J. 1982 . "High-dose destyrosine-gamma-endorphin in tardive dyskinesia" . Psychopharmacology (Berl) , 78 : 285 – 286 .
   PubMedGoogle Scholar
• Kramer , M.S. 2000 . "Update on substance P (NK-1 receotir) antagonists in clinical trials for depression" . Neuropeptides , 34 : 255
   PubMed Web of Science ®Google Scholar
• Kramer , M.S. , Cutler , N. , Feighner , J. , Shrivastava , R. , Carman , J. , Sramek , J.J. , Reines , S.A. , Liu , G. , Snavely , D. , Wyatt-Knowles , E. , Hale , J.J. , Mills , S.G. , MacCoss , M. , Swain , C.J. , Harrison , T. , Hill , R.G. , Hefti , F. , Scolnick , E.M. , Cascieri , M.A. , Chicchi , G.G. , Sadowski , S. , Williams , A.R. , Hewson , L. , Smith , D. Rupniak , N.M. 1998 . "Distinct mechanism for antidepressant activity by blockade of central substance P receptors" . Science , 281 : 1640 – 1645 .
   PubMed Web of Science ®Google Scholar
• Lahti , R.A. , Cochrane , E.V. , Roberts , R.C. , Conley , R.R. and Tamminga , C.A. 1998 . "[3H]Neurotensin receptor densities in human postmortem brain tissue obtained from normal and schizophrenic persons. An autoradiographic study" . J. Neural Transm. , 105 (4-5) : 507 – 516 .
   PubMedGoogle Scholar
• Laruelle , M. , Seghers , A. , Goffinet , S. , Bouchez , S. and Legros , J.J. 1990 . "Plasmatic vasopressin neurophysin in depression: basic levels and relations with HPA axis" . Biol. Psychiatry , 27 : 1249 – 1263 .
   PubMedGoogle Scholar
• Leake , A. , Perry , E.K. , Perry , R.H. , Fairbairn , A.F. and Ferrier , I.N. 1990 . "Cortical concentrations of corticotropin-releasing hormone and its receptor in Alzheimer type dementia and major depression" . Biol. Psychiatry , 28 : 603 – 608 .
   PubMedGoogle Scholar
• Legros , J.J. and Louis , F. 1973 . "Identification of a vasopressin-neurophysin and of an oxytocin-neurophysin in man" . Neuroendocrinology , 13 : 371 – 375 .
   Google Scholar
• Legros , J.J. , Gazzotti , C. , Carvelli , T. , Franchimont , P. , Timsit-Berthier , M. , von Frenckell , R. and Ansseau , M. 1992 . "Apomorphine stimulation of vasopressin- and oxytocin-neurophysins. Evidence for increased oxytocinergic and decreased vasopressinergic function in schizophrenics" . Psychoneuroendocrinology , 17 : 611 – 617 .
   PubMed Web of Science ®Google Scholar
• Leibowitz , S.F. 1994 . "Specificity of hypothalamic peptides in the control of behavioral and physiological processes" . Ann. NY Acad. Sci. , 739 : 12 – 35 .
   PubMed Web of Science ®Google Scholar
• Lembeck , F. 1953 . "Zur Frage der zentralen Übertragung afferenter Impulse. III. Mittelung. Den Vorkommen und die Bedeutung der Substanz P in den dorsalen Wurzeln des RÜckenmarks" . Arch. Exp. Pathol. Pharmakol. , 219 : 197 – 213 .
   PubMedGoogle Scholar
• Lenzinger , E. , Meszaros , K. , Hornik , K. , Parzer , P. , Hollerer , E. , Langer , G. , Resch , F. and Legros , J.J. 1996 . "Correlation between vasopressin baseline and TSH-blunting in depressives" . Biol. Psychiatry , 39 : 341 – 345 .
   PubMedGoogle Scholar
• Lesch , K.P. , Laux , G. , Pfuller , H. , Erb , A. and Beckmann , H. 1987 . "Growth hormone (GH) response to GH-releasing hormone in depression" . J. Clin. Endocrinol. Metab. , 65 : 1278 – 1281 .
   PubMed Web of Science ®Google Scholar
• Lesch , K.P. , Widerlov , E. , Ekman , R. , Laux , G. , Rupprecht , R. , Schulte , H.M. and Beckmann , H. 1989 . "The influence of human corticotropin-releasing hormone on somatostatin secretion in depressed patients and controls" . J. Neural Transm. , 75 : 111 – 118 .
   PubMedGoogle Scholar
• Lindstrom , L.H. , Widerlov , E. , Bisette , G. and Nemeroff , C. 1988 . "Reduced CSF neurotensin concentration in drug-free schizophrenic patients" . Schizophr. Res. , 1 (1) : 55 – 59 .
   PubMedGoogle Scholar
• Linkowski , P. , Geenen , V. , Kerkhofs , M. , Mendlewicz , J. and Legros , J.J. 1984 . "Cerebrospinal fluid neurophysins in affective illness and in schizophrenia" . Eur. Arch. Psychiatry Neurol. Sci. , 234 : 162 – 165 .
   PubMedGoogle Scholar
• Liu , R.Y. , Zhou , J.N. , Hoogendijk , W.J. , Van Heerikhuize , J. , Kamphorst , W. , Unmehopa , U.A. , Hofman , M.A. and Swaab , D.F. 2000 . "Decreased vasopressin gene expression in the biological clock of Alzheimer disease patients with and without depression" . J. Neuropathol. Exp. Neurol. , 59 : 314 – 322 .
   PubMed Web of Science ®Google Scholar
• Lolait , S.J. , O'Carroll , A.M. , Mahan , L.C. , Felder , C.C. , Button , D.C. , Young , W.S. III , Mezey , E. and Brownstein , M.J. 1995 . "Extrapituitary expression of the rat V1b vasopressin receptor gene" . Proc. Natl Acad. Sci. USA , 92 : 6783 – 6787 .
   PubMed Web of Science ®Google Scholar
• Lotstra , F. , Verbanck , P. , Mendlewicz , J. and Vanderhaeghen , J.J. 1984 . "No evidence of antipsychotic effect of caerulein in schizophrenic patients free of neuroleptics: a double-blind cross-over study" . Biol. Psychiatry , 19 : 877 – 882 .
   PubMedGoogle Scholar
• Mai , J.K. , Berger , K. and Sofroniew , M.V. 1993 . "Morphometric evaluation of neurophysin-immunoreactivity in the human brain: pronounced inter-individual variability and evidence for altered staining patterns in schizophrenia" . J. Hirnforsch. , 34 : 133 – 154 .
   PubMedGoogle Scholar
• Manchanda , R. and Hirsch , S.R. 1981 . "(Des-Tyr)-gamma-endorphin in the treatment of schizophrenia" . Psychol. Med. , 11 : 401 – 404 .
   PubMedGoogle Scholar
• Mattes , J.A. , Hom , W. and Rochford , J.M. 1985a . "A high-dose, double-blind study of ceruletide in the treatment of schizophrenia" . Am. J. Psychiatry , 142 : 1482 – 1484 .
   PubMedGoogle Scholar
• Mattes , J.A. , Hom , W. , Rochford , J.M. and Orlosky , M. 1985b . "Ceruletide for schizophrenia: a double-blind study" . Biol. Psychiatry , 20 : 533 – 538 .
   PubMedGoogle Scholar
• Mauri , M.C. , Rudelli , R. , Vanni , S. , Panza , G. , Sicaro , A. , Audisio , D. , Sacerdote , P. and Panerai , A.E. 1998 . "Cholecystokinin, beta-endorphin and vasoactive intestinal peptide in peripheral blood mononuclear cells of drug-naive schizophrenic patients treated with haloperidol compared to healthy controls" . Psychiatry Res. , 78 : 45 – 50 .
   PubMedGoogle Scholar
• McMahon , B.M. , Boules , M. , Warrington , L. and Richelson , E. 2002 . "Neurotensin analogs indications for use as potential antipsychotic compounds" . Life Sci. , 70 (10) : 1101 – 1119 .
   PubMedGoogle Scholar
• Meltzer , H.Y. , Busch , D.A. , Tricou , B.J. and Robertson , A. 1982 . "Effect of (Des-Tyr)-gamma-endorphin in schizophrenia" . Psychiatry Res. , 6 : 313 – 326 .
   PubMedGoogle Scholar
• Miller , C. , Kirchmair , R. , Troger , J. , Saria , A. , Fleischhacker , W.W. , Fischer-Colbrie , R. , Benzer , A. and Winkler , H. 1996 . "CSF of neuroleptic-naive first-episode schizophrenic patients: levels of biogenic amines, substance P and peptides derived from chromogranin A (GE-25) and secretogranin II (secretoneurin)" . Biol. Psychiatry , 39 : 911 – 918 .
   PubMedGoogle Scholar
• Mizuki , Y. , Ushijima , I. , Yamada , M. , Tanaka , M. and Inanaga , K. 1986 . "A treatment trial with an analog of thyrotropin-releasing hormone (DN-1417) and des-tyrosine-gamma-endorphin in schizophrenia" . Int. Clin. Psychopharmacol. , 1 : 303 – 313 .
   PubMedGoogle Scholar
• Modell , S. , Lauer , C.J. , Schreiber , W. , Huber , J. , Krieg , J.C. and Holsboer , F. 1998 . "Hormonal response pattern in the combined DEX-CRH test is stable over time in subjects at high familial risk for affective disorders" . Neuropsychopharmacology , 18 : 253 – 262 .
   PubMed Web of Science ®Google Scholar
• Molchan , S.E. , Lawlor , B.A. , Hill , J.L. , Martinez , R.A. , Davis , C.L. , Mellow , A.M. , Rubinow , D.R. and Sunderland , T. 1991 . "CSF monoamine metabolites and somatostatin in Alzheimer's disease and major depression" . Biol. Psychiatry , 29 : 1110 – 1118 .
   PubMedGoogle Scholar
• Molchan , S.E. , Hill , J.L. , Martinez , R.A. , Lawlor , B.A. , Mellow , A.M. , Rubinow , D.R. , Bissette , G. , Nemeroff , C.B. and Sunderland , T. 1993 . "CSF somatostatin in Alzheimer's disease and major depression: relationship to hypothalamic-pituitary-adrenal axis and clinical measures" . Psychoneuroendocrinology , 18 : 509 – 519 .
   PubMed Web of Science ®Google Scholar
• Montgomery , S.A. , Green , M. , Rimon , R. , Heikkila , L. , Forsstrom , R. , Hirsch , S.R. , Hallstrom , C. , Hippius , H. , Naber , R. Khan , M.C. 1992 . "Inadequate treatment response to des-enkephalin-gamma-endorphin compared with thioridazine and placebo in schizophrenia" . Acta Psychiatr. Scand. , 86 : 97 – 103 .
   PubMedGoogle Scholar
• Nair , N.P. , Bloom , D.M. , Debonnel , G. , Schwartz , G. and Mosticyan , S. 1984 . "Cholecystokinin-octapeptide in chronic schizophrenia: a double-blind placebo-controlled study" . Prog. Neuropsychopharmacol. Biol. Psychiatry , 8 : 711 – 714 .
   PubMedGoogle Scholar
• Nakase , S. , Kitayama , I. , Soya , H. , Hamanaka , K. and Nomura , J. 1998 . "Increased expression of magnocellular arginine vasopressin mRNA in paraventricular nucleus of stress-induced depression-model rats" . Life Sci. , 63 : 23 – 31 .
   PubMedGoogle Scholar
• Nemeroff , C.B. 1980 . "Neurotensin: perchance an endogenous neuroleptic?" . Biol. Psychiatry , 15 (2) : 283 – 302 .
   PubMedGoogle Scholar
• Nemeroff , C.B. , Youngblood , W.W. , Manberg , P.J. , Prange , A.J. Jr. and Kizer , J.S. 1983 . "Regional brain concentrations of neuropeptides in Huntington's chorea and schizophrenia" . Science , 221 (4614) : 972 – 975 .
   PubMedGoogle Scholar
• Nemeroff , C.B. , Widerlov , E. , Bissette , G. , Walleus , H. , Karlsson , I. , Eklund , K. , Kilts , C.D. , Loosen , P.T. and Vale , W. 1984 . "Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients" . Science , 226 : 1342 – 1344 .
   PubMed Web of Science ®Google Scholar
• Nemeroff , C.B. , Owens , M.J. , Bissette , G. , andorn , A.C. and Stanley , M. 1988 . "Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims" . Arch. Gen. Psychiatry , 45 : 577 – 579 .
   PubMed Web of Science ®Google Scholar
• Nemeroff , C.B. , Bissette , G. , Widerlov , E. , Beckmann , H. , Gerner , R. , Manberg , P.J. , Lindstrom , L. , Prange , A.J. Jr. and Gattaz , W.F. 1989 . "Neurotensin-like immunoreactivity in cerebrospinal fluid of patients with schizophrenia, depression, anorexia nervosa-bulimia, and premenstrual syndrome" . J. Neuropsychiatry Clin. Neurosci. , 1 (1) : 16 – 20 .
   PubMedGoogle Scholar
• Nilsson , C. , Karlsson , G. , Blennow , K. , Heilig , M. and Ekman , R. 1996 . "Differences in the neuropeptide Y-like immunoreactivity of the plasma and platelets of human volunteers and depressed patients" . Peptides. , 17 (3) : 359 – 362 .
   PubMedGoogle Scholar
• Ordway , G.A. , Stockmeier , C.A. , Meltzer , H.Y. , Overholser , J.C. , Jaconetta , S. and Widdowson , P.S. 1995 . "Neuropeptide Y in frontal cortex is not altered in major depression" . J. Neurochem. , 65 (4) : 1646 – 1650 .
   PubMedGoogle Scholar
• Palacios , J.M. , Rigo , M. , Chinaglia , G. and Probst , A. 1990 . "Reduced density of striatal somatostatin receptors in Huntington's chorea" . Brain Res. , 522 (2) : 342 – 346 .
   PubMedGoogle Scholar
• Palacios , J.M. , Chinaglia , G. , Rigo , M. , Ulrich , J. and Probst , A. 1991 . "Neurotensin receptor binding levels in basal ganglia are not altered in Huntington's chorea or schizophrenia" . Synapse , 7 (2) : 114 – 122 .
   PubMedGoogle Scholar
• Panza , G. , Monzani , E. , Sacerdote , P. , Penati , G. and Panerai , A.E. 1992 . "Beta-endorphin, vasoactive intestinal peptide and cholecystokinin in peripheral blood mononuclear cells from healthy subjects and from drug-free and haloperidol-treated schizophrenic patients" . Acta Psychiatr. Scand. , 85 : 207 – 210 .
   PubMedGoogle Scholar
• Peselow , E. , Angrust , B. , Sudilovsky , A. , Corwin , J. , Siekierski , J. , Trent , F. and Rotrosen , J. 1987 . "Double blind controlled trials of cholecystokinin octapeptide in neuroleptic-refractory schizophrenia" . Psychopharmacology (Berl). , 91 : 80 – 84 .
   PubMedGoogle Scholar
• Peters , J. , Van Kammen , D.P. , Gelernter , J. , Yao , J. and Shaw , D. 1990 . "Neuropeptide Y-like immunoreactivity in schizophrenia. Relationships with clinical measures" . Schizophr. Res. , 3 (5,6) : 287 – 294 .
   PubMedGoogle Scholar
• Pitts , A.F. , Samuelson , S.D. , Meller , W.H. , Bissette , G. , Nemeroff , C.B. and Kathol , R.G. 1995 . "Cerebrospinal fluid corticotropin-releasing hormone, vasopressin and oxytocin concentrations in treated patients with major depression and controls" . Biol. Psychiatry , 38 : 330 – 335 .
   PubMed Web of Science ®Google Scholar
• Prange , A.J. Jr. , Wilson , I.C. , Breese , G.R. and Lipton , M.A. 1975 . "Behavioral effects of hypothalamic releasing hormones in animals and men" . Prog. Brain Res. , 42 : 1 – 9 .
   PubMedGoogle Scholar
• Price , L.H. , Cappiello , A. , Malison , R.T. , McDougle , C.J. , Pelton , G.H. , Schollnhammer , G. and Heninger , G.R. 1997 . "Effects of antiglucocorticoid treatment on 5-HT1A function in depressed patients and healthy subjects" . Neuropsychopharmacology , 17 : 246 – 257 .
   PubMedGoogle Scholar
• Purba , J.S. , Hoogendijk , W.J. , Hofman , M.A. and Swaab , D.F. 1996 . "Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression" . Arch. Gen. Psychiatry , 53 : 137 – 143 .
   PubMed Web of Science ®Google Scholar
• Raadsheer , F.C. , Hoogendijk , W.J. , Stam , F.C. , Tilders , F.J. and Swaab , D.F. 1994 . "Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients" . Neuroendocrinology , 60 : 436 – 444 .
   PubMed Web of Science ®Google Scholar
• Raadsheer , F.C. , Van Heerikhuize , J.J. , Lucassen , P.J. , Hoogendijk , W.J. , Tilders , F.J. and Swaab , D.F. 1995 . "Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression" . Am. J. Psychiatry , 152 : 1372 – 1376 .
   PubMed Web of Science ®Google Scholar
• Rafaelsen , O.J. and Gjerris , A. 1985 . "Neuropeptides in the cerebrospinal fluid (CSF) in psychiatric disorders" . Prog. Neuropsychopharmacol. Biol. Psychiatry , 9 : 533 – 538 .
   PubMedGoogle Scholar
• Raskind , M. , Orenstein , H. and Weitzman , R.E. 1979 . "Vasopressin in depression" . Lancet , 1 : 164
   PubMed Web of Science ®Google Scholar
• Reinikainen , K.J. , Koponen , H. , Jolkkonen , J. and Riekkinen , P.J. 1990 . "Decreased somatostatin-like immunoreactivity in the cerebrospinal fluid of chronic schizophrenic patients with cognitive impairment" . Psychiatry Res. , 33 (3) : 307 – 312 .
   PubMedGoogle Scholar
• Rimon , R. , Le Greves , P. , Nyberg , F. , Heikkila , L. , Salmela , L. and Terenius , L. 1984 . "Elevation of substance P-like peptides in the CSF of psychiatric patients" . Biol. Psychiatry , 19 : 509 – 516 .
   PubMed Web of Science ®Google Scholar
• Rioux , L. , Nissanov , J. and Joyce , J.N. 1998 . "Increased number of [ 125 I] BH-substance P in schizophrenia" . Prog. Neuropsychopharmacol. Biol. Psychiatry , 22 : 1295 – 1299 .
   Google Scholar
• Risch , S.C. , Lewine , R.J. , Jewart , R.D. , Pollard , W.E. , Caudle , J.M. , Kalin , N.H. , Stipetic , M. , Eccard , M.B. and Risby , E.D. 1991 . "Relationship between cerebrospinal fluid peptides and neurotransmitters in depression" ” . In Central Nervous System Peptide Mechanisms in Stress and Depression , Edited by: Risch , S.C. Washington DC : American Psychiatric Press .
   Google Scholar
• Roberts , G.W. , Ferrier , I.N. , Lee , Y. , Crow , T.J. , Johnstone , E.C. , Owens , D.G. , Bacarese-Hamilton , A.J. , McGregor , G. , O'Shaughnessey , D. and Polak , J.M. 1983 . "Peptides, the limbic lobe and schizophrenia" . Brain Res. , 288 : 199 – 211 .
   PubMedGoogle Scholar
• Ronken , E. , Wiegant , V.M. , Kaspersen , F.M. , Van Nispen , J.W. , De Boer , T. , Bruning , H.W. , Rust , C.J. and Tonnaer , J.A. 1993 . "Topography and characteristics of specific binding sites for non-opioid gamma-type endorphins in the rat brain as studied by autoradiography with [35S]Met-desenkephalin-gamma-endorphin" . Brain Res. , 615 : 63 – 70 .
   PubMedGoogle Scholar
• Roy , A. , Pickar , D. , Paul , S. , Doran , A. , Chrousos , G.P. and Gold , P.W. 1987 . "CSF corticotropin-releasing hormone in depressed patients and normal control subjects" . Am. J. Psychiatry , 144 : 641 – 645 .
   PubMed Web of Science ®Google Scholar
• Roy , B.F. , Benkelfat , C. , Hill , J.L. , Pierce , P.F. , Dauphin , M.M. , Kelly , T.M. , Sunderland , T. , Weinberger , D.R. and Breslin , N. 1994a . "Serum antibody for somatostatin-14 and prodynorphin 209-240 in patients with obsessive-compulsive disorder, schizophrenia, Alzheimer's disease, multiple sclerosis, and advanced HIV infection" . Biol. Psychiatry , 35 (5) : 335 – 344 .
   PubMedGoogle Scholar
• Roy , A. , Wolkowitz , O.M. , Bissette , G. and Nemeroff , C.B. 1994b . "Differences in CSF concentrations of thyrotropin-releasing hormone in depressed patients and normal subjects: negative findings" . Am. J. Psychiatry , 151 : 600 – 602 .
   PubMedGoogle Scholar
• Rubinow , D.R. , Gold , P.W. , Post , R.M. , Ballenger , J.C. , Cowdry , R. , Bollinger , J. and Reichlin , S. 1983 . "CSF somatostatin in affective illness" . Arch. Gen. Psychiatry , 40 : 409 – 412 .
   PubMed Web of Science ®Google Scholar
• Rupniak , N.M. and Kramer , M.S. 1999 . "Discovery of the antidepressant and anti-emetic efficacy of substance P receptor (NK1) antagonists" . Trends Pharmacol. Sci. , 20 : 485 – 490 .
   PubMed Web of Science ®Google Scholar
• Saiz-Ruiz , J. , Carrasco , J.L. , Martin , M. , Manzanares , J. and Hernanz , A. 1992 . "Plasmatic somatostatin as a marker of positive symptoms of schizophrenia" . Prog. Neuropsychopharmacol. Biol. Psychiatry , 16 (2) : 203 – 210 .
   PubMedGoogle Scholar
• Santarelli , L. , Gobbi , G. , Debs , P.C. , Sibille , E.T. , Blier , P. , Hen , R. and Heath , M.J. 2001 . "Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function" . Proc. Natl Acad. Sci. USA , 98 : 1912 – 1917 .
   PubMed Web of Science ®Google Scholar
• Sattin , A. 1998 . "A heuristic model of mental depression derived from basic and applied research on thyrotropin-releasing hormone" . Thyroid , 8 : 957 – 962 .
   PubMedGoogle Scholar
• Sawchenko , P.E. , Imaki , T. , Potter , E. , Kovacs , K. , Imaki , J. and Vale , W. 1993 . "The functional neuroanatomy of corticotropin-releasing factor" . Ciba Found. Symp. , 172 : 5 – 21 .
   PubMedGoogle Scholar
• Scott , L.V. and Dinan , T.G. 1998 . "Vasopressin and the regulation of hypothalamic-pituitary-adrenal axis function: implications for the pathophysiology of depression" . Life Sci. , 62 : 1985 – 1998 .
   PubMed Web of Science ®Google Scholar
• Sharma , R.P. , Janicak , P.G. , Bissette , G. and Nemeroff , C.B. 1997 . "CSF neurotensin concentrations and antipsychotic treatment in schizophrenia and schizoaffective disorder" . Am. J. Psychiatry , 154 (7) : 1019 – 1021 .
   PubMedGoogle Scholar
• Siuciak , J.A. , Lewis , D.R. , Wiegand , S.J. and Lindsay , R.M. 1997 . "Antidepressant-like effect of brain-derived neurotrophic factor (BDNF)" . Pharmacol. Biochem. Behav. , 56 : 131 – 137 .
   PubMed Web of Science ®Google Scholar
• Sorensen , P.S. , Gjerris , A. and Hammer , M. 1985 . "Cerebrospinal fluid vasopressin in neurological and psychiatric disorders" . J. Neurol. Neurosurg. Psychiatry , 48 : 50 – 57 .
   PubMed Web of Science ®Google Scholar
• Staner , L. , Duval , F. , Calvi-Gries , F. , Mokrani , M.C. , Bailey , P. , Hode , Y. , Toussaint , M. , Luthringer , R. , Muzet , A. and Macher , J.P. 2001 . "Morning and evening TSH response to TRH and sleep EEG disturbances in major depressive disorder" . Prog. Neuropsychopharmacol. Biol. Psychiatry , 25 : 535 – 547 .
   PubMedGoogle Scholar
• Steckler , T. , Holsboer , F. and Reul , J.M. 1999 . "Glucocorticoids and depression" . Bailliere's Best. Pract. Res. Clin. Endocrinol. Metab. , 13 : 597 – 614 .
   PubMed Web of Science ®Google Scholar
• Tamminga , C.A. , Tighe , P.J. , Chase , T.N. , DeFraites , E.G. and Schaffer , M.H. 1981 . "Des-tyrosine-gamma-endorphin administration in chronic schizophrenics. A preliminary report" . Arch. Gen. Psychiatry , 38 : 167 – 168 .
   PubMedGoogle Scholar
• Tamminga , C.A. , Littman , R.L. , Alphs , L.D. , Chase , T.N. , Thaker , G.K. and Wagman , A.M. 1986 . "Neuronal cholecystokinin and schizophrenia: pathogenic and therapeutic studies" . Psychopharmacology (Berl) , 88 : 387 – 391 .
   PubMed Web of Science ®Google Scholar
• Tang , Q. , Gandhoke , R. , Burritt , A. , Hruby , V.J. , Porreca , F. and Lai , J. 1999 . "High-affinity interaction of (des-Tyrosyl)dynorphin A(2-17) with NMDA receptors" . J. Pharmacol. Exp. Ther. , 291 : 760 – 765 .
   PubMedGoogle Scholar
• Tooney , P.A. , Crawter , V.C. and Chahl , L.A. 2001 . "Increased tachykinin NK(1) receptor immunoreactivity in the prefrontal cortex in schizophrenia" . Biol. Psychiatry , 49 : 523 – 527 .
   PubMedGoogle Scholar
• Toru , M. , Watanabe , S. , Shibuya , H. , Nishikawa , T. , Noda , K. , Mitsushio , H. , Ichikawa , H. , Kurumaji , A. , Takashima , M. and Mataga , N. 1988 . "Neurotransmitters, receptors and neuropeptides in post-mortem brains of chronic schizophrenic patients" . Acta Psychiatr. Scand. , 78 : 121 – 137 .
   PubMed Web of Science ®Google Scholar
• Traskman-Bendz , L. , Ekman , R. , Regnell , G. and Ohman , R. 1992 . "HPA-related CSF neuropeptides in suicide attempters" . Eur. Neuropsychopharmacol. , 2 : 99 – 106 .
   PubMedGoogle Scholar
• Van Kammen , D.P. , Waters , R.N. Gold , P. 1981 . "Spinal fluid vasopressin, angiotensin I and II, beta-endorphin and opioid activity in schizophrenia: a preliminary evaluation" ” . In Biological Psychiatry , Edited by: Perris , C. , Struwe , G. and Jansson , B. Amsterdam : Elsevier/North-Holland Biomedical Press .
   Google Scholar
• Van Londen , L. , Goekoop , J.G. , Van Kempen , G.M. , Frankhuijzen-Sierevogel , A.C. , Wiegant , V.M. , Van der Velde , E.A. and De Wied , D. 1997 . "Plasma levels of arginine vasopressin elevated in patients with major depression" . Neuropsychopharmacology , 17 : 284 – 292 .
   PubMed Web of Science ®Google Scholar
• Van Londen , L. , Kerkhof , G.A. , Van den , B.F. , Goekoop , J.G. , Zwinderman , K.H. , Frankhuijzen-Sierevogel , A.C. , Wiegant , V.M. and De Wied , D. 1998 . "Plasma arginine vasopressin and motor activity in major depression" . Biol. Psychiatry , 43 : 196 – 204 .
   PubMed Web of Science ®Google Scholar
• Van Londen , L. , Goekoop , J.G. , Kerkhof , G.A. , Zwinderman , K.H. , Wiegant , V.M. and De Wied , D. 2001 . "Weak 24-h periodicity of body temperature and increased plasma vasopressin in melancholic depression" . Eur. Neuropsychopharmacol. , 11 : 7 – 14 .
   PubMed Web of Science ®Google Scholar
• Verbanck , P.M. , Lotstra , F. , Gilles , C. , Linkowski , P. , Mendlewicz , J. and Vanderhaeghen , J.J. 1984 . "Reduced cholecystokinin immunoreactivity in the cerebrospinal fluid of patients with psychiatric disorders" . Life Sci. , 34 : 67 – 72 .
   PubMedGoogle Scholar
• Verhoeven , W.M. , Van Praag , H.M. , Van Ree , J.M. and De Wied , D. 1979 . "Improvement of schizophrenic patients treated with [des-Tyr1]-gamma-endorphin (DTgammaE)" . Arch. Gen. Psychiatry , 36 : 294 – 298 .
   PubMed Web of Science ®Google Scholar
• Verhoeven , W.M. , Van Ree , J.M. , De Wied , D. and Van Praag , H.M. 1981 . "Gamma-Type endorphins and schizophrenia" . Arch. Gen. Psychiatry , 38 : 1182 – 1183 .
   PubMedGoogle Scholar
• Verhoeven , W.M. , Westenberg , H.G. and Van Ree , J.M. 1986 . "A comparative study on the antipsychotic properties of desenkephalin-gamma-endorphin and ceruletide in schizophrenic patients" . Acta Psychiatr. Scand. , 73 : 372 – 382 .
   PubMed Web of Science ®Google Scholar
• Verhoeven , W.M. , Van Ree , J.M. , Westenberg , H.G. , Krul , J.M. , Brouwer , G.J. , Thijssen , J.H. , De Wied , D. , Van Praag , H.M. , Ceulemans , D.L. and Kahn , R.S. 1984 . "Clinical, biochemical, and hormonal aspects of treatment with Des-tyr1-gamma-endorphin in schizophrenia" . Psychiatry Res. , 11 : 329 – 346 .
   PubMedGoogle Scholar
• Virgo , L. , Humphries , C. , Mortimer , A. , Barnes , T. , Hirsch , S. and De Belleroche , J. 1995 . "Cholecystokinin messenger RNA deficit in frontal and temporal cerebral cortex in schizophrenia" . Biol. Psychiatry , 37 : 694 – 701 .
   PubMedGoogle Scholar
• Volavka , J. , Hui , K.S. , Anderson , B. , Nemes , Z. , O'Donnell , J. and Lajtha , A. 1983 . "Short-lived effect of (Des-Tyr)-gamma-endorphin in schizophrenia" . Psychiatry Res. , 10 : 243 – 252 .
   PubMedGoogle Scholar
• von Bardeleben , U. and Holsboer , F. 1989 . "Cortisol response to a combined dexamethason-hCRH challenge in patients with depression" . J. Neuroendocrinol. , 1 : 485 – 488 .
   PubMed Web of Science ®Google Scholar
• von Bardeleben , U. , Holsboer , F. , Stalla , G.K. and Muller , O.A. 1985 . "Combined administration of human corticotropin-releasing factor and lysine vasopressin induces cortisol escape from dexamethasone suppression in healthy subjects" . Life Sci. , 37 : 1613 – 1618 .
   PubMed Web of Science ®Google Scholar
• Wei , J. and Hemmings , G.P. 1999 . "The CCK-A receptor gene possibly associated with auditory hallucinations in schizophrenia" . Eur. Psychiatry , 14 : 67 – 70 .
   PubMed Web of Science ®Google Scholar
• Westrin , A. , Ekman , R. and Traskman-Bendz , L. 1999 . "Alterations of corticotropin releasing hormone (CRH) and neuropeptide Y (NPY) plasma levels in mood disorder patients with a recent suicide attempt" . Eur. Neuropsychopharmacol. , 9 (3) : 205 – 211 .
   PubMedGoogle Scholar
• Westrin , A. , Ekman , R. , Regnell , G. and Traskman-Bendz , L. 2001 . "A follow up study of suicide attempters: increase of CSF-somatostatin but no change in CSF-CRH" . Eur. Neuropsychopharmacol. , 11 : 135 – 143 .
   PubMed Web of Science ®Google Scholar
• Widdowson , P.S. , Ordway , G.A. and Halaris , A.E. 1992 . "Reduced neuropeptide Y concentrations in suicide brain" . J. Neurochem. , 59 : 73 – 80 .
   PubMed Web of Science ®Google Scholar
• Widerlov , E. , Lindstrom , L.H. , Besev , G. , Manberg , P.J. , Nemeroff , C.B. , Breese , G.R. , Kizer , J.S. and Prange , A.J. Jr. 1982 . "Subnormal CSF levels of neurotensin in a subgroup of schizophrenic patients: normalization after neuroleptic treatment" . Am. J. Psychiatry , 139 (9) : 1122 – 1126 .
   PubMedGoogle Scholar
• Widerlov , E. , Lindstrom , L.H. , Wahlestedt , C. and Ekman , R. 1988a . "Neuropeptide Y peptide YY as possible cerebrospinal fluid markers for major depression and schizophrenia, respectively" . J. Psychiatr. Res. , 22 (1) : 69 – 79 .
   PubMedGoogle Scholar
• Widerlov , E. , Bissette , G. and Nemeroff , C.B. 1988b . "Monoamine metabolites, corticotropin releasing factor and somatostatin as CSF markers in depressed patients" . J. Affect. Disord. , 14 : 99 – 107 .
   PubMed Web of Science ®Google Scholar
• Wiegant , V.M. , Ronken , E. , Kovacs , G. and De Wied , D. 1992 . "Endorphins and schizophrenia" . Prog. Brain Res. , 93 : 433 – 453 .
   PubMedGoogle Scholar
• Wolf , S.S. , Hyde , T.M. , Saunders , R.C. , Herman , M.M. , Weinberger , D.R. and Kleinman , J.E. 1995 . "Autoradiographic characterization of neurotensin receptors in the entorhinal cortex of schizophrenic patients and control subjects" . J. Neural. Transm. Gen. Sect. , 102 (1) : 55 – 65 .
   PubMedGoogle Scholar
• Wolkowitz , O.M. and Reus , V.I. 1999 . "Treatment of depression with antiglucocorticoid drugs" . Psychosom. Med. , 61 : 698 – 711 .
   PubMed Web of Science ®Google Scholar
• Wong , M.L. , Kling , M.A. , Munson , P.J. , Listwak , S. , Licinio , J. , Prolo , P. , Karp , B. , McCutcheon , I.E. , Geracioti , T.D. Jr. , DeBellis , M.D. , Rice , K.C. , Goldstein , D.S. , Veldhuis , J.D. , Chrousos , G.P. , Oldfield , E.H. , McCann , S.M. and Gold , P.W. 2000 . "Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone" . Proc. Natl Acad. Sci. USA , 97 : 325 – 330 .
   PubMed Web of Science ®Google Scholar
• Yamamura , Y. , Ogawa , H. , Chihara , T. , Kondo , K. , Onogawa , T. , Nakamura , S. , Mori , T. , Tominaga , M. and Yabuuchi , Y. 1991 . "OPC-21268, an orally effective, nonpeptide vasopressin V1 receptor antagonist" . Science , 252 : 572 – 574 .
   PubMed Web of Science ®Google Scholar
• Zachrisson , O. , De Belleroche , J. , Wendt , K.R. , Hirsch , S. and Lindefors , N. 1999 . "Cholecystokinin CCK(B) receptor mRNA isoforms: expression in schizophrenic brains" . Neuroreport , 10 : 3265 – 3268 .
   PubMedGoogle Scholar
• Zech , M. and Bogerts , B. 1985 . "Methionine-enkephalin and substance P in the basal ganglia of normals, Parkinson patients, Huntington patients and schizophrenics. A qualitative immunohistochemical study" . Acta Neuropathol. (Berl) , 68 : 32 – 38 .
   PubMedGoogle Scholar
• Zech , M. , Roberts , G.W. , Bogerts , B. , Crow , T.J. and Polak , J.M. 1986 . "Neuropeptides in the amygdala of controls, schizophrenics and patients suffering from Huntington's chorea: an immunohistochemical study" . Acta Neuropathol. (Berl) , 71 (3-4) : 259 – 266 .
   PubMedGoogle Scholar
• Zhou , J.N. , Riemersma , R.F. , Unmehopa , U.A. , Hoogendijk , W.J. , Van Heerikhuize , J.J. , Hofman , M.A. and Swaab , D.F. 2001 . "Alterations in arginine vasopressin neurons in the suprachiasmatic nucleus in depression" . Arch. Gen. Psychiatry , 58 : 655 – 662 .
   PubMedGoogle Scholar
• Zobel , A.W. , Nickel , T. , Kunzel , H.E. , Ackl , N. , Sonntag , A. , Ising , M. and Holsboer , F. 2000 . "Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated" . J. Psychiatry Res. , 34 : 171 – 181 .
   PubMed Web of Science ®Google Scholar
• Zohar , J. , Drummer , D. , Edelstein , E.D. , Kaiser , N. , Belmaker , R.H. and Nir , I. 1985 . "Effect of lysine vasopressin in depressed patients on mood and 24-hour rhythm of growth hormone, cortisol, melatonin and prolactin" . Psychoneuroendocrinology , 10 : 273 – 279 .
   PubMedGoogle Scholar